Founder And Director
CurrentNB Solutions provide strategic advice around clinical research technology/data to a portfolio of small and mid-size clinical technology, CRO, HEOR and pharma/biotech companies, as well as a select set of investment companies whose focus is in the digital health space. Working with Founders, Boards and CEO we act as a trusted partner to companies looking to scale their business and reach their next investment milestone. Successful engagements include:Ignite Data - leaders in agnostic interoperability between EHR and EDC who successfully closed seed funding of $8mAlgorics a biostatistics CRO who were acquired by Precision for Medicine MyMeds&Me specialists in the capture of safety information who were acquired by Stanley Capital and now form part of QinecsaCisiv - experts in collating and curating real world data who took funding to expand their platformDue diligence on behalf of PE in for both eClinical and CRO transactions of UK, European and US companies. Working on a project or retained basis, experience we can bring to the relationship includes:Supporting clinical technology companies as they scale-up• Commercialisation and go-to-market strategies• Customer success and operational governance programmes• Entering new global regions and building capability• Integration of newly acquired entities into the parent organisation Finding (and growing) the correct investment and acquisition opportunities in both the decentralised trials technology arena and CRO space• Competitive landscape assessment • Due diligence, from potential fit, to a deep dive before investment • Non-exec / investor-board liaison, after investmentIdentifying and implementing a clinical technology roadmap for pharma/biotech and CRO• Opportunity from new digital approaches• Running virtual/decentralised trials• Assessment of how such a transformation will impact the business - both people and process• Driving sustained patient centric change through ePRO and wearables
